PRODUCT DETAILS

Product Image

OXRA 5MG TABLETS (Dapagliflozin 5mg) Diabetes & Kidney Support

$

OXRA 5MG TABLETS contain Dapagliflozin 5mg, an SGLT2 inhibitor prescribed for type 2 diabetes management and used to support cardiovascular and kidney health in suitable patients.

Unit:
  • N/A
Total: $

 

OXRA 5MG TABLETS (Dapagliflozin 5mg) Diabetes & Kidney Support

 

OXRA 5MG TABLETS contain Dapagliflozin 5mg, an SGLT2 inhibitor prescribed for type 2 diabetes management and used to support cardiovascular and kidney health in suitable patients.

 

OXRA 5MG TABLETS

OXRA 5MG TABLETS (DAPAGLIFLOZIN 5MG): Comprehensive Guide and Benefits

Introduction to OXRA 5MG TABLETS (DAPAGLIFLOZIN 5MG)

OXRA 5MG TABLETS: An SGLT2 Inhibitor for Blood Sugar Management

OXRA 5MG TABLETS contain Dapagliflozin 5mg, a medicine belonging to the Sodium-Glucose Cotransporter-2 (SGLT2) inhibitor class. It is an oral antidiabetic medicine prescribed for the management of type 2 diabetes mellitus and may be used in selected patients for cardiovascular and kidney-related benefits according to medical guidelines.

Dapagliflozin works by helping the kidneys remove excess glucose through urine, thereby reducing blood glucose levels. OXRA 5MG TABLETS are prescription medicines and should be used only under the guidance of a healthcare professional.

Key Benefits of OXRA 5MG TABLETS (DAPAGLIFLOZIN 5MG)

Helps improve blood sugar control in adults with type 2 diabetes.

Supports reduction of excess glucose levels by increasing urinary glucose removal.

May provide cardiovascular and kidney benefits in appropriate patients.

Can be used alone or along with other diabetes medicines as prescribed.

Provides once-daily oral therapy for diabetes management. 

How OXRA 5MG TABLETS Works

OXRA contains Dapagliflozin, which blocks the action of SGLT2 proteins in the kidneys.

Normally, SGLT2 helps reabsorb glucose back into the bloodstream. By inhibiting this transporter, Dapagliflozin reduces glucose reabsorption and allows excess glucose to leave the body through urine. This mechanism helps lower blood glucose levels.

Usage Instructions for OXRA 5MG TABLETS

Take OXRA 5MG TABLETS exactly as prescribed by your doctor.

Swallow the tablet whole with water.

It may be taken with or without food.

Try to take it at the same time every day.

Do not stop the medicine without consulting your healthcare provider.

Maintain regular monitoring of blood glucose and kidney function as advised. 

Medicinal Advantages of OXRA 5MG TABLETS

Helps control elevated blood sugar levels in type 2 diabetes.

Works through an insulin-independent mechanism.

May assist in reducing glucose load through urinary elimination.

Supports diabetes management when combined with diet and lifestyle modifications.

May provide additional kidney and heart-related benefits in selected patients. 

NOTE: OXRA 5MG TABLETS should be used carefully in patients with kidney problems, dehydration risk, or recurrent urinary/genital infections. Regular medical monitoring is recommended.

Off-Label Uses of OXRA 5MG TABLETS

Dapagliflozin may be evaluated by specialists for uses beyond its primary indications depending on clinical evidence and individual patient needs.

Possible specialist-guided applications may include:

Additional cardiovascular risk management strategies.

Specific kidney-related treatment approaches.

Disclaimer: Off-label use should only be considered under qualified medical supervision.

Expert Advice for Optimal Use

Follow the prescribed dose schedule carefully.

Drink adequate fluids unless your doctor has advised fluid restriction.

Monitor blood sugar levels regularly.

Maintain a healthy diet and exercise routine.

Inform your doctor before surgery or prolonged fasting.

Report symptoms of infection, dehydration, or unusual weakness.

Precautions

Kidney Function

Kidney function should be assessed before and during treatment because Dapagliflozin acts through the kidneys and may require medical evaluation in patients with reduced kidney function.

Blood Sugar Control

Patients taking insulin or sulfonylureas may have an increased risk of low blood sugar when combined therapy is used. Dose adjustments may be required by a doctor.

Pregnancy & Breastfeeding

OXRA 5MG TABLETS are generally not recommended during pregnancy or breastfeeding unless specifically advised by a healthcare professional.

Drug Interactions

Inform your doctor if you take:

Insulin or other diabetes medicines

Diuretics (water tablets)

Blood pressure medicines

Kidney-affecting medicines

Herbal supplements

Existing Medical Conditions

Tell your doctor if you have:

Kidney disease

Frequent urinary infections

Low blood pressure

Dehydration

History of diabetic ketoacidosis

Storage Instructions

Store below 30°C.

Keep tablets in the original blister packaging.

Protect from moisture and direct sunlight.

Keep away from children.

Do not use after the expiry date. 

Frequently Asked Questions (FAQs)

Q: What is OXRA 5MG TABLETS used for?

A: OXRA 5MG TABLETS are used for managing type 2 diabetes mellitus by helping lower blood glucose levels.

Q: What is the active ingredient in OXRA 5MG?

A: The active ingredient is Dapagliflozin 5mg, an SGLT2 inhibitor.

Q: Is OXRA 5MG an insulin medicine?

A: No. OXRA contains Dapagliflozin and works by increasing glucose removal through the kidneys rather than replacing insulin.

Q: Can OXRA 5MG be taken without a prescription?

A: No. OXRA 5MG TABLETS are prescription medicines and should be taken only under medical supervision.

Q: What are common side effects of OXRA 5MG?

A: Possible side effects may include increased urination, urinary tract infections, genital infections, dehydration, dizziness, and changes in blood sugar levels.

Q: Does OXRA 5MG help with weight management?

A: Dapagliflozin may cause some patients to experience weight reduction due to glucose loss through urine, but it should be used primarily for approved medical indications under doctor supervision.

Product Tags

OXRA 5MG TABLETS, Dapagliflozin 5mg, Dapagliflozin Tablet, SGLT2 Inhibitor, Type 2 Diabetes Medicine, Antidiabetic Tablet, Blood Sugar Control Medicine, Diabetes Management Tablet, Kidney Support Medicine, Cardiovascular Diabetes Therapy, Oral Diabetes Medication, Prescription Diabetes Medicine, Glucose Lowering Tablet, OXRA Tablet, Sun Pharma Dapagliflozin, Metabolic Disorder Medicine, Chronic Disease Management Medicine.

Jonathan Andrew

Happy Customer

Review

Post Your Review